Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
301
Stocks News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,602.70 | 101.70 | -1.32% |
| CAC 40 | 7,100.42 | 173.30 | 2.50% |
| DAX 40 | 20,280.26 | 490.64 | 2.48% |
| Dow JONES (US) | 37,645.59 | 2,900.34 | -7.15% |
| FTSE 100 | 7,910.53 | 144.45 | -1.79% |
| HKSE | 19,480.48 | 647.20 | -3.22% |
| NASDAQ | 15,267.91 | 1,282.69 | -7.75% |
| Nikkei 225 | 31,934.02 | 1,078.56 | -3.27% |
| NZX 50 Index | 11,847.24 | 44.20 | -0.37% |
| S&P 500 | 4,982.77 | 79.48 | -1.57% |
| S&P/ASX 200 | 7,416.40 | 93.60 | -1.25% |
| SSE Composite Index | 3,094.93 | 50.62 | -1.61% |